Shilpa Medicare Ltd Share Price Live
Live Shilpa Medicare Share Price Chart
Shilpa Medicare Performance
Days Range
| Previous Close | ₹350.15 |
|---|---|
| Open | ₹349.8 |
| Volume | 1,81,647 |
| Day's Range | ₹340.00 - ₹349.95 |
|---|---|
| 52W Range | ₹277.50 - ₹500.00 |
| Market Cap | ₹6,827.76 Cr |
Shilpa Medicare Fundamentals
| ROCE(TTM) | 8.41 |
|---|---|
| P/E Ratio (TTM) | 49.73 |
| P/B Ratio | 2.8 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.24 |
| ROE | 6.35 |
| EPS (TTM) | 7.91 |
| Dividend Yield | 0.14 |
| Book Value | 124.61 |
| Face Value | 1 |
| ROCE(TTM) | 8.41 |
|---|---|
| P/E Ratio (TTM) | 49.73 |
| P/B Ratio | 2.8 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.24 |
| ROE | 6.35 |
|---|---|
| EPS (TTM) | 7.91 |
| Dividend Yield | 0.14 |
| Book Value | 124.61 |
| Face Value | 1 |
Shilpa Medicare Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 319.30 | 330.80 | 321.46 | 369.97 |
| Expenses | 267.43 | 282.86 | 258.74 | 291.51 |
| Profit before tax | 41.61 | 15.27 | 49.58 | 64.43 |
| Operating Profit | 31.78 | 14.51 | 46.89 | 44.07 |
| Net Profit | 31.78 | 14.51 | 46.89 | 44.07 |
| ESP in Rs | 3.25 | 4.88 | 4.79 | 5.50 |
Shilpa Medicare Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 44.33% | 44.23% | 44.23% | 44.23% | 44.23% |
| Flls | 9.58% | 9.9% | 10.97% | 11.2% | 10.92% |
| Dlls | 8.18% | 8.27% | 7.55% | 7.46% | 7.67% |
| Public | 37.9% | 37.6% | 37.25% | 37.11% | 37.18% |
About Shilpa Medicare
Shilpa Medicare Ltd., formerly known as Shilpa Antibiotics was incorporated as a private limited company in Nov.'87 and has been promoted by Vishnukant C Bhutada and his associates.The company produces trimethoprim, an anti-biotic bulk drug. It also manufactures the product for other reputed companies like Eskayef, Bombay Drugs & Pharmas, Bombay Drug House, US Vitamins, Sandoz India, etc, for their export commitments.
Circa 1992, the company installed production facilities to manufacture sodium methoxide.
SAL is the recipient of the World Health Organisation - Good Manufacturing Practices (GMP) certificate. It exports its products to hard-currency areas. The company manufactures 1-methyl, amino-1-methyl, thio-2-nitro ethane, a drug intermediate used in the manufacture of ranitidine, an anti-ulcer drug.
The company proposes to embark upon an expansion project which involves the addition of one more bulk drug to its existing product range -- norfloxacin -- and expand the production capacity of the existing products of the company -- sodium methoxide and trimethoprim.
Parent Organisation
Indian Private
Managing Director
Omprakash Inani
Founded
1987
NSE Symbol
SHILPAMED
Top Mutual Funds Invested in Shilpa Medicare Share
Top Mutual Funds Invested in Shilpa Medicare Share
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,831.1 20.80 (1.15%) | ₹4,34,159.66 | 1,548.0 - 1,910.0 |
| Divis Laboratories Ltd | 6,471.0 -19.50 (-0.30%) | ₹1,72,287.78 | 4,955.0 - 7,071.5 |
| Torrent Pharmaceuticals Ltd | 3,722.0 -8.40 (-0.23%) | ₹1,26,434.15 | 2,886.45 - 3,882.2 |
| Cipla Ltd | 1,530.9 5.70 (0.37%) | ₹1,23,148.76 | 1,335.0 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,257.1 7.80 (0.62%) | ₹1,04,369.38 | 1,020.0 - 1,405.9 |
| Lupin Ltd | 2,085.1 13.70 (0.66%) | ₹94,659.39 | 1,795.2 - 2,402.9 |
Popular stocks
Shilpa Medicare Ltd FAQs
What is the share price of Shilpa Medicare Ltd (SHILPAMED) shares?
Shilpa Medicare Ltd (SHILPAMED) share price as of November 28, 2025, on NSE is Rs 341.5 (NSE) and Rs 341.5 (BSE) on BSE.
Can I buy Shilpa Medicare Ltd (SHILPAMED) from Angel One?
Yes, You can buy Shilpa Medicare Ltd (SHILPAMED) shares by opening a Demat account with Angel One.
How do I buy Shilpa Medicare Ltd (SHILPAMED) from Angel One?
Shilpa Medicare Ltd (SHILPAMED) share can be bought through the following modes:
1. Direct investment: You can buy Shilpa Medicare Ltd (SHILPAMED) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shilpa Medicare Ltd (SHILPAMED) shares.
1. Direct investment: You can buy Shilpa Medicare Ltd (SHILPAMED) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shilpa Medicare Ltd (SHILPAMED) shares.
What is the main business of Shilpa Medicare?
Shilpa Medicare specialises in the production of superior-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty chemicals.
Who are the promoters of Shilpa Medicare?
Vishnukant Chaturbhuj Bhutada, Dharmavati Bhutada and Ravi Kumar Innani are the major promoters of Shilpa Medicare.
What are the Subsidiaries that comes under Shilpa Medicare?
INM Technologies Private Limited, Shilpa Therapeutics Private Limited, INM Nuvent Paints Private Limited (Step-Down Subsidiary), and Shilpa Biocare Private Limited are the subsidiaries that come under Shilpa Medicare.
